Table of Contents
<< Previous Issue | Sept 2018 (Vol: 2018, Issue: 9) | Next Issue >> |
- Section: Licensing
-
LEO Pharma Signs US$402 M Dermatology Deal with JW Pharmaceutical
- Section: Mergers & Acquisitions
-
Aurobindo to Bolster Generics Portfolio with US$1 B Sandoz Deal
-
Alexion to Acquire Antibody Specialist Syntimmune for US$1.2 B
- Section: Opinion & Analysis
-
IQVIA Pharma Deals: Half-Year Review of 2018
- Section: Research & Development
-
Affimed Enters into US$5 B Cancer Immunotherapy Collaboration with Genentech
-
Ironwood Ends US$265 M Gout Collaboration with AstraZeneca